Cargando…
Alternative Tobacco Product Use in Critically Ill Patients
Background: Alternative tobacco product (ATP) use has bee linked to critical illness, however, few studies have examined the use of these substances in critically ill populations. We sought to examine ATP use within critically ill patients and to define barriers in accurately assessing use within th...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727672/ https://www.ncbi.nlm.nih.gov/pubmed/33255164 http://dx.doi.org/10.3390/ijerph17238707 |
_version_ | 1783621111172300800 |
---|---|
author | Liu, Tom Deiss, Thomas J. Lippi, Matthew W. Jauregui, Alejandra Vessel, Kathryn Ke, Serena Belzer, Annika Zhuo, Hanjing Kangelaris, Kirsten N. Gomez, Antonio D. Matthay, Michael A. Liu, Kathleen D. Calfee, Carolyn S. |
author_facet | Liu, Tom Deiss, Thomas J. Lippi, Matthew W. Jauregui, Alejandra Vessel, Kathryn Ke, Serena Belzer, Annika Zhuo, Hanjing Kangelaris, Kirsten N. Gomez, Antonio D. Matthay, Michael A. Liu, Kathleen D. Calfee, Carolyn S. |
author_sort | Liu, Tom |
collection | PubMed |
description | Background: Alternative tobacco product (ATP) use has bee linked to critical illness, however, few studies have examined the use of these substances in critically ill populations. We sought to examine ATP use within critically ill patients and to define barriers in accurately assessing use within this population. Methods: We prospectively studied 533 consecutive patients from the Early Assessment of Renal and Lung Injury study, enrolled between 2013 and 2016 at a tertiary referral center and a safety-net hospital. ATP use information (electronic cigarettes, cigars, pipes, hookahs/waterpipes, and snus/chewing tobacco) was obtained from the patient or surrogate using a detailed survey. Reasons for non-completion of the survey were recorded, and differences between survey responders vs. non-responders, self- vs. surrogate responders, and ATP users vs. non-users were explored. Results: Overall, 80% (n = 425) of subjects (56% male) completed a tobacco product use survey. Of these, 12.2% (n = 52) reported current ATP use, while 5.6% reported using multiple ATP products. When restricted to subjects who were self-responders, 17% reported ATP use, while 10% reported current cigarette smoking alone. The mean age of ATP users was 57 ± 17 years. Those who did not complete a survey were sicker and more likely to have died during admission. Subjects who completed the survey as self-responders reported higher levels of ATP use than ones with surrogate responders (p < 0.0001). Conclusion: ATP use is common among critically ill patients despite them being generally older than traditional users. Survey self-responders were more likely than surrogate responders to report use. These findings highlight the importance of improving our current methods of surveillance of ATP use in older adults in the outpatient setting. |
format | Online Article Text |
id | pubmed-7727672 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77276722020-12-11 Alternative Tobacco Product Use in Critically Ill Patients Liu, Tom Deiss, Thomas J. Lippi, Matthew W. Jauregui, Alejandra Vessel, Kathryn Ke, Serena Belzer, Annika Zhuo, Hanjing Kangelaris, Kirsten N. Gomez, Antonio D. Matthay, Michael A. Liu, Kathleen D. Calfee, Carolyn S. Int J Environ Res Public Health Article Background: Alternative tobacco product (ATP) use has bee linked to critical illness, however, few studies have examined the use of these substances in critically ill populations. We sought to examine ATP use within critically ill patients and to define barriers in accurately assessing use within this population. Methods: We prospectively studied 533 consecutive patients from the Early Assessment of Renal and Lung Injury study, enrolled between 2013 and 2016 at a tertiary referral center and a safety-net hospital. ATP use information (electronic cigarettes, cigars, pipes, hookahs/waterpipes, and snus/chewing tobacco) was obtained from the patient or surrogate using a detailed survey. Reasons for non-completion of the survey were recorded, and differences between survey responders vs. non-responders, self- vs. surrogate responders, and ATP users vs. non-users were explored. Results: Overall, 80% (n = 425) of subjects (56% male) completed a tobacco product use survey. Of these, 12.2% (n = 52) reported current ATP use, while 5.6% reported using multiple ATP products. When restricted to subjects who were self-responders, 17% reported ATP use, while 10% reported current cigarette smoking alone. The mean age of ATP users was 57 ± 17 years. Those who did not complete a survey were sicker and more likely to have died during admission. Subjects who completed the survey as self-responders reported higher levels of ATP use than ones with surrogate responders (p < 0.0001). Conclusion: ATP use is common among critically ill patients despite them being generally older than traditional users. Survey self-responders were more likely than surrogate responders to report use. These findings highlight the importance of improving our current methods of surveillance of ATP use in older adults in the outpatient setting. MDPI 2020-11-24 2020-12 /pmc/articles/PMC7727672/ /pubmed/33255164 http://dx.doi.org/10.3390/ijerph17238707 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Liu, Tom Deiss, Thomas J. Lippi, Matthew W. Jauregui, Alejandra Vessel, Kathryn Ke, Serena Belzer, Annika Zhuo, Hanjing Kangelaris, Kirsten N. Gomez, Antonio D. Matthay, Michael A. Liu, Kathleen D. Calfee, Carolyn S. Alternative Tobacco Product Use in Critically Ill Patients |
title | Alternative Tobacco Product Use in Critically Ill Patients |
title_full | Alternative Tobacco Product Use in Critically Ill Patients |
title_fullStr | Alternative Tobacco Product Use in Critically Ill Patients |
title_full_unstemmed | Alternative Tobacco Product Use in Critically Ill Patients |
title_short | Alternative Tobacco Product Use in Critically Ill Patients |
title_sort | alternative tobacco product use in critically ill patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727672/ https://www.ncbi.nlm.nih.gov/pubmed/33255164 http://dx.doi.org/10.3390/ijerph17238707 |
work_keys_str_mv | AT liutom alternativetobaccoproductuseincriticallyillpatients AT deissthomasj alternativetobaccoproductuseincriticallyillpatients AT lippimattheww alternativetobaccoproductuseincriticallyillpatients AT jaureguialejandra alternativetobaccoproductuseincriticallyillpatients AT vesselkathryn alternativetobaccoproductuseincriticallyillpatients AT keserena alternativetobaccoproductuseincriticallyillpatients AT belzerannika alternativetobaccoproductuseincriticallyillpatients AT zhuohanjing alternativetobaccoproductuseincriticallyillpatients AT kangelariskirstenn alternativetobaccoproductuseincriticallyillpatients AT gomezantoniod alternativetobaccoproductuseincriticallyillpatients AT matthaymichaela alternativetobaccoproductuseincriticallyillpatients AT liukathleend alternativetobaccoproductuseincriticallyillpatients AT calfeecarolyns alternativetobaccoproductuseincriticallyillpatients |